Literature DB >> 29796836

The Severity of Spinal Cord Injury Determines the Inflammatory Gene Expression Pattern after Immunization with Neural-Derived Peptides.

Elisa García1,2, Raúl Silva-García3, Adrian Flores-Romero1,2, Liliana Blancas-Espinoza3, Roxana Rodríguez-Barrera1,2, Antonio Ibarra4,5.   

Abstract

Previous studies revealed that the intensity of spinal cord injury (SCI) plays a key role in the therapeutic effects induced by immunizing with neural-derived peptides (INDP), as severe injuries abolish the beneficial effects induced by INDP. In the present study, we analyzed the expression of some inflammation-related genes (IL6, IL12, IL-1β, IFNɣ, TNFα, IL-10, IL-4, and IGF-1) by quantitative PCR in rats subjected to SCI and INDP. We investigated the expression of these genes after a moderate or severe contusion. In addition, we evaluated the effect of INDP by utilizing two different peptides: A91 and Cop-1. After moderate injury, both A91 and Cop-1 elicited a pattern of genes characterized by a significant reduction of IL6, IL1β, and TNFα but an increase in IL10, IL4, and IGF-1 expression. There was no effect on IL-12 and INFɣ. In contrast, the opposite pattern was observed when rats were subjected to a severe spinal cord contusion. Immunization with either peptide caused a significant increase in the expression of IL-12, IL-1β, IFNɣ (pro-inflammatory genes), and IGF-1. There was no effect on IL-4 and IL-10 compared to controls. After a moderate SCI, INDP reduced pro-inflammatory gene expression and generated a microenvironment prone to neuroprotection. Nevertheless, severe injury elicits the expression of pro-inflammatory genes that could be aggravated by INDP. These findings correlate with our previous results demonstrating that severe injury inhibits the beneficial effects of protective autoimmunity.

Entities:  

Keywords:  Gene expression; Neural-derived peptides; Spinal cord injury

Mesh:

Substances:

Year:  2018        PMID: 29796836     DOI: 10.1007/s12031-018-1077-3

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  48 in total

1.  Autoimmune T cells as potential neuroprotective therapy for spinal cord injury.

Authors:  E Hauben; U Nevo; E Yoles; G Moalem; E Agranov; F Mor; S Akselrod; M Neeman; I R Cohen; M Schwartz
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

Review 2.  Anti-TNF therapy in the injured spinal cord.

Authors:  Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Trends Pharmacol Sci       Date:  2010-12-23       Impact factor: 14.819

3.  Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury.

Authors:  K L Brewer; J R Bethea; R P Yezierski
Journal:  Exp Neurol       Date:  1999-10       Impact factor: 5.330

4.  Gene profiling in spinal cord injury shows role of cell cycle in neuronal death.

Authors:  Simone Di Giovanni; Susan M Knoblach; Cinzia Brandoli; Sadia A Aden; Eric P Hoffman; Alan I Faden
Journal:  Ann Neurol       Date:  2003-04       Impact factor: 10.422

Review 5.  Targeting the host inflammatory response in traumatic spinal cord injury.

Authors:  John R Bethea; W Dalton Dietrich
Journal:  Curr Opin Neurol       Date:  2002-06       Impact factor: 5.710

Review 6.  TLR-dependent T cell activation in autoimmunity.

Authors:  Kingston H G Mills
Journal:  Nat Rev Immunol       Date:  2011-11-18       Impact factor: 53.106

7.  Analysis of gene expression following spinal cord injury in rat using complementary DNA microarray.

Authors:  Toshiya Tachibana; Koichi Noguchi; M A Ruda
Journal:  Neurosci Lett       Date:  2002-07-19       Impact factor: 3.046

8.  Vaccination with a neural-derived peptide plus administration of glutathione improves the performance of paraplegic rats.

Authors:  S Martiñon; E García; N Flores; I Gonzalez; T Ortega; M Buenrostro; R Reyes; A M Fernandez-Presas; G Guizar-Sahagún; D Correa; A Ibarra
Journal:  Eur J Neurosci       Date:  2007-07-10       Impact factor: 3.386

9.  The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse.

Authors:  K E Abraham; D McMillen; K L Brewer
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

10.  Development of protective autoimmunity by immunization with a neural-derived peptide is ineffective in severe spinal cord injury.

Authors:  Susana Martiñón; Elisa García; Gabriel Gutierrez-Ospina; Humberto Mestre; Antonio Ibarra
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

View more
  2 in total

1.  Neuroprotective effect of immunomodulatory peptides in rats with traumatic spinal cord injury.

Authors:  Dulce Parra-Villamar; Liliana Blancas-Espinoza; Elisa Garcia-Vences; Juan Herrera-García; Adrian Flores-Romero; Alberto Toscano-Zapien; Jonathan Vilchis Villa; Rodríguez Barrera-Roxana; Soria Zavala Karla; Antonio Ibarra; Raúl Silva-García
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

Review 2.  Immunomodulation induced by central nervous system-related peptides as a therapeutic strategy for neurodegenerative disorders.

Authors:  María Laura Palumbo; Alejandro David Moroni; Sofía Quiroga; María Micaela Castro; Adriana Laura Burgueño; Ana María Genaro
Journal:  Pharmacol Res Perspect       Date:  2021-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.